required, Life/Health Sciences preferred Job Level: Management Why Biogen? We are a global team with a commitment.... Caring Deeply. Achieving Excellence. Changing Lives. At Biogen, we are committed to building on our culture of inclusion...
Lugar:
Tokyo | 03/03/2026 19:03:03 PM | Salario: S/. No Especificado | Empresa:
Biogen expert knowledgeable of Biogen products, disease state and competitors Establishes long term scientific/strategic... relationships such that Biogen is recognized as an industry partner of choice Plan KME visits and utilize the CRM database...
Lugar:
Tokyo | 20/02/2026 21:02:24 PM | Salario: S/. No Especificado | Empresa:
Biogen a strong commitment to ethical behavior and Biogen Code of Business Conduct Continuous Improvement and Project Management Support... language Job Level: Management Why Biogen? We are a global team with a commitment to excellence, and a pioneering spirit...
Lugar:
Tokyo | 20/02/2026 01:02:44 AM | Salario: S/. No Especificado | Empresa:
Biogen, from early development to J‑NDA submission and approval for Biogen programs. Key Responsibilities: Lead the preparation... experience in global drug development is preferred. Job Level: Management Why Biogen? We are a global team...
Lugar:
Tokyo | 17/02/2026 01:02:03 AM | Salario: S/. No Especificado | Empresa:
Biogen knowledgeable of Biogen products, disease state and competitors Establishes long term scientific/strategic relationships... relationships such that Biogen is recognized as an industry partner of choice Plan KME visits and utilize the CRM database...
Lugar:
Tokyo | 14/02/2026 18:02:22 PM | Salario: S/. No Especificado | Empresa:
Biogen Education Requirements 学⼠号 MR資格 Job Level: Management Why Biogen? We are a global team with a commitment to excellence.... Achieving Excellence. Changing Lives. At Biogen, we are committed to building on our culture of inclusion and belonging...
Lugar:
Tokyo | 13/02/2026 23:02:33 PM | Salario: S/. No Especificado | Empresa:
Biogen類株発行による第三者割当増資を実施 2021年4月 Biogen MA, Inc.との間で、共同研究開発およびオプション付きライセンス契約を締結 2021年9月 C種種類株発行による第三者割当増資を実施 2023年4月 D種種類株発行による第三者割当増資を実施 【募集...
1